![]() |
|
|
Vol. 293, Issue 1, 196-205, April 2000
Department of Cardiac Physiology, National Cardiovascular Center Research Institute, Suita, Osaka, Japan (H.K., M.Ya.); First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan (H.K., M.Yo., H.A.); and Department of Pharmacology II, Faculty of Medicine, Osaka University, Osaka, Japan (K.M., Y.K.)
| |
Abstract |
|---|
|
|
|---|
Tertiapin is a 21-residue peptide isolated from honey bee
venoms. A recent study indicated that tertiapin is a potent blocker of
certain types of inwardly rectifying K+ (Kir) channels (Jin
and Lu, 1998
). We examined the effect of tertiapin on ion channel
currents in rabbit cardiac myocytes using the patch-clamp technique. In
the whole-cell configuration, tertiapin fully inhibited acetylcholine
(1 µM)-induced muscarinic K+ (KACh) channel
currents in atrial myocytes with the half-maximum inhibitory
concentration of ~8 nM through ~1:1 stoichiometry. The potency of
tertiapin in inhibiting KACh channels was not significantly different at
40 and
100 mV. Tertiapin also inhibited the
KACh channel preactivated by intracellular guanosine
5'-O-(3-thiotriphosphate), a nonhydrolyzable GTP analog.
A constitutively active Kir channel, the IK1 channel, was
at least 100 times less sensitive to tertiapin. Another Kir channel in
cardiac myocytes, the ATP-sensitive K+ channel, was
virtually insensitive to tertiapin (1 µM). The voltage-dependent K+ and the L-type Ca2+ channels
were not affected by tertiapin (1 µM). At the single-channel level,
tertiapin inhibited the KACh channel from the outside of the membrane by reducing the NPo (N is the number of
functional channels, and the Po is the open probability of
each channel) without affecting the single-channel conductance or fast
kinetics. Therefore, tertiapin potently and selectively blocks the
KACh channel in cardiac myocytes in a receptor- and
voltage-independent manner. Tertiapin is a novel pharmacological tool
to identify the functional role of the KACh channel in the
parasympathetic regulation of the heart beat.
| |
Introduction |
|---|
|
|
|---|
Tertiapin
is a peptide composed of 21 amino acids (Fig.
1) that was initially isolated from
venoms of the European honey bee, Apis mellifera, more than
20 years ago (Gauldie et al., 1976
). This peptide has six positively
charged residues in a molecule, four of which are clustered within the
C-terminal half of the polypeptide chain. Tertiapin completely lacks
negatively charged residues, and the lysine at the carboxyl end is in
an amide form. Four cysteines in the peptide form two disulfide bonds.
NMR spectroscopy revealed that tertiapin has a type-I reverse turn and
an
-helix, which are connected by a loop of an extended
-sheet
(Xu and Nelson, 1993
). The three-dimensional structure of tertiapin is
highly compact due to extensive side chain interaction. Different from other bee peptidyl toxins, such as apamin and mast cell-degranulating peptide, the biological target of tertiapin had not been known until
Jin and Lu (1998)
found that tertiapin potently blocks certain types of
recombinant inwardly rectifying K+ (Kir)
channels. Although there are many known peptidyl toxins blocking the
voltage-dependent K+ channels (Adams and Swanson,
1996
), tertiapin is the sole potent Kir channel blocker identified so
far.
|
Kir channels are highly K+-selective ion channels
that carry K+ ions from extracellular to
intracellular space more efficiently than in the other direction
(Nichols and Lopatin, 1997
). This inwardly rectifying property allows
the channels to fix the cell resting membrane potential toward the
K+ equilibrium potential
(EK) (~
85 mV under physiological condition) without preventing action potential generation (Hille, 1992
). There are
multiple distinct types of Kir channels that differ in the extent of
inward rectification. Some of them completely shut outward
K+ currents at the membrane potential more
positive than EK +60 mV (strong inward
rectifiers), whereas others permit large outward currents even at
EK +200 mV (weak inward rectifiers). Kir channels are also diverse in the regulation of activity. Some Kir channels are
constitutively active, but others are regulated by various intracellular signaling molecules, such as G proteins, nucleotides, protein kinase/phosphatase, and anchoring proteins (Yamada et al.,
1998
).
Kir channels play a particularly important role in such a cell type as
cardiac myocytes, where the resting potential is
~EK, whereas the action potential duration is
as long as several hundred milliseconds. Cardiac myocytes possess three
distinct types of Kir channels (Isomoto et al., 1997
). The
IK1 channel is a constitutively active, strong
inward rectifier and determines the basic electrophysiological property
of working ventricular myocytes and some atrial myocytes. Nodal,
atrial, and Purkinje myocytes have another inward rectifier, muscarinic
K+ (KACh) channel,
whose inward rectification is slightly weaker than that of the
IK1 channel (Yamada et al., 1998
).
KACh channels have a low basal activity and are
activated by acetylcholine (ACh), adenosine, and
sphingosine-1-phosphate. Receptors recognizing these substances
activate the pertussis toxin-sensitive heterotrimeric G protein, which
in turn directly activates the channels through its 
-subunit.
This signaling pathway mediates the negative chronotropic and
dromotropic effects caused by the substances. The third Kir channel is
a weak inward rectifier, the ATP-sensitive K+
(KATP) channel (Terzic et al., 1995
). This
channel is completely inhibited by millimolar concentrations of
intracellular ATP in normal cardiac myocytes. When the ATP level
decreases on ischemia, the channel is activated and evokes
K+ currents, which markedly shorten the action
potential duration to attenuate contraction.
Differential expression and regulation of these Kir channels in cardiac myocytes are fundamental requirements for the physiological heart beat. However, the lack of specific blockers of these channels has impeded the direct demonstration of the role of the IK1 and KACh channels in the cardiac physiology. Thus, we examined the effect of tertiapin on ion channel currents in cardiac myocytes. We show here that tertiapin potently and selectively blocks KACh channels. Tertiapin is, therefore, a useful pharmacological tool to identify the functional role of KACh channels in the cardiac physiology and pathophysiology.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Isolation. Male Japanese-White rabbits weighing 1.5 to 2.5 kg were treated with heparin sodium (200 U/kg b.wt.) injected via an ear vein. Approximately 20 min later, the rabbits were anesthetized with pentobarbital sodium (30 mg/kg b.wt.) applied through a vein in another ear. As soon as rabbits completely lost a nociceptive response, the heart was quickly removed and mounted on the Langendorff apparatus. The heart was immediately reperfused with the oxygenated control bathing solution (for composition, see later) through coronary arteries at 37°C. When the heart exhibited a stable sinus rhythm, the solution was switched to the oxygenated nominally Ca2+-free Tyrode's solution (for composition, see later). When the heart completely ceased contraction, the solution was exchanged to the same solution containing 0.04% (w/w) collagenase. After 5 to 10 min of digestion, the heart was perfused with 60 ml of KB solution (for composition, see later) and stored in the fresh KB solution at 4°C until use.
Electrophysiological Measurement. A small piece of tissue was excised from the digested myocardium with fine scissors and gently shaken in the control bathing solution in an experimental chamber mounted on the stage of a vertical microscope (Axiovert S100; Carl Zeiss, Jana, Germany). When myocytes dissociated from the shaken tissue stuck to the glass bottom of the chamber, the control bathing solution was perfused through a gravity-feeding apparatus connected to the chamber.
Cell membrane currents were measured from myocytes with smooth surface and clear striations by the patch-clamp method (Hamill et al., 1981
in the control bathing solution when
filled with the internal solution or the K+
external solution (for compositions, see later). After the liquid junction potential was electrically removed, the giga-ohm seal was
formed with continuously applied 10-ms voltage steps from 0 to +10 mV
at 16 Hz under the voltage-clamp condition.
For the whole-cell configuration, the pipette was filled with the
internal solution containing 3 mM ATP and 100 µM GTP unless otherwise
indicated. After formation of the giga-ohm seal, the pipette potential
was switched to
40 mV, and the patch membrane was ruptured with
gentle suction applied to the pipette. The cell capacitative current
was electrically removed with the amplifier. The series resistance was
3.9 ± 0.2 M
(mean ± S.E., n = 73) and routinely compensated by 90%. Whole-cell membrane currents were measured at the gain of 0.5 to 2 mV/pA. The voltage command pulses were
applied to the amplifier through its external command input from a data
acquisition board (AT-MIO-16X; National Instruments, Austin, TX)
equipped on a personal computer (GP5-200; Gateway 2000, N. Sioux City,
SD). This board was driven by a homemade program written with LabVIEW
for Windows (National Instruments, Austin, TX).
In the cell-attached and the inside-out configurations, pipettes were
filled with the K+ external solution, and the
chamber was perfused with the internal solution. For the outside-out
configuration, the pipette solution was the same as in the whole-cell
configuration, whereas the outside of the patch membrane was perfused
with the K+ external solution. In single-channel
recordings, the gain of the amplifier was set at 100 mV/pA.
Throughout experiments, the current and voltage outputs
of the amplifier were continuously monitored with a digital
oscilloscope (DCS-720; Kenwood, Tokyo, Japan) and recorded on a paper
with an analog thermal array recorder (RTA-1100; Nihon Kohden, Tokyo, Japan) after low-pass filtering at 2 kHz (
3 dB) with a four-pole Bessel filter (multifunction filter 3611; NF Electronic Instruments, Yokohama, Japan). For off-line analyses, the data were filtered at 10 kHz, sampled at 47.2 kHz by the PCM recorder (VR10B; Instrutech Co.,
Long Island, NY), and stored on a video cassette tape by a video
cassette recorder (SLV-675HF; Sony, Tokyo, Japan). These data were
subsequently reproduced by the same PCM recorder, filtered at 1 to 2 kHz, digitized at 3 to 5 kHz with an AD converter (ITC-16i; Instrutech
Co., Long Island, NY), and then analyzed with another computer (Power
Macintosh G3; Apple, Cupertino, CA) and commercially available software
(Patch Analyst Pro; MT Corporation, Hyogo, Japan). For spectral
analysis of single-channel current fluctuations, the reproduced data
were filtered at 5 kHz (
3 dB) with a Butterworth filter and digitized
at 12.5 kHz. The data were divided into short segments of 8192 points
and were multiplied point by point by a Blackman Harris window function
and then Fourier transformed. Power density spectrum was constructed,
subtracted from that in the absence of channel openings, and fit with
the following sum of Lorentzian functions:
|
(1) |
Solutions. The control bathing solution contained 136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.5 mM HEPES (pH adjusted to 7.4 with NaOH). Nominally Ca2+-free Tyrode's solution was the same in composition as the control bathing solution except that no CaCl2 was added. The KB solution contained 10 mM taurine, 10 mM oxalic acid, 70 mM glutamic acid, 25 mM KCl, 10 mM KH2PO4, 11 mM glucose, 0.5 mM EGTA, and 10 mM HEPES (pH adjusted to 7.3 with KOH). The internal solution contained 140 mM KCl, 2 mM MgCl2, 5 mM EGTA, and 5 mM HEPES (pH adjusted to 7.4 with KOH). The concentration of free Mg2+ in this solution was calculated to be 1.4 mM. When nucleotides such as ATP and GTP were added to the internal solution, MgCl2 was supplemented to maintain the free Mg2+ concentration. The K+ external solution contained 140 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES (pH adjusted to 7.4 with KOH).
According to the manufacturer's recommendation, tertiapin was dissolved in distilled water at 100 µM, dispensed into small aliquots in polypropylene tubes, and stored at
20°C until use. Immediately
before use, the peptide was diluted to the desired concentration in
vehicles in polypropylene tubes. ACh and guanosine 5'-O-(3-thiotriphosphate) (GTP
S) were dissolved at 10 mM and 100 µM, respectively, in distilled water and stored at
20°C as small aliquots until use. ATP and GTP were prepared daily
from powder and stored at 4°C until use.
Chemicals.
Tertiapin was a kind gift from Peptide Institute
Inc. (Osaka, Japan). Acetylcholine chloride, ATP (dipotassium salt),
and GTP
S were purchased from Sigma Chemical Co. (St. Louis, MO). Pentobarbital sodium was obtained from Dainippon Pharmaceutical Co.
Ltd. (Osaka, Japan). Heparin sodium was obtained from Aventis (Frankfurt, Germany). Collagenase was obtained from Yakult (Tokyo, Japan). GTP and all other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan).
| |
Results |
|---|
|
|
|---|
Effect of Tertiapin on Ion Channel Currents in Rabbit Atrial
Myocytes.
We measured membrane currents from a rabbit atrial
myocyte in the whole-cell configuration (Fig.
2A). From the holding potential of
40
mV, 500-ms voltage pulses between
100 and +40 mV were applied to the
cell in a 10-mV increment every 5 s. In the control condition (a),
the hyperpolarizing voltage steps to potentials more negative than
70
mV elicited inward IK1 currents (Sakmann and
Trube, 1984
; Kurachi, 1985
). The currents were promptly activated and
then slightly decreased. On repolarization to
40 mV, a large inward
Na+ current was evoked (Brown et al., 1981
). When
the membrane was depolarized to the potentials more positive than
40
mV, the slow inward Ca2+
(ICa) current appeared (McDonald et al., 1994
),
which was followed by gradually developing outward voltage-dependent
K+ (IK) currents
(Sanguinetti and Jurkiewicz, 1990
). Repolarization to
40 mV from
these potentials elicited the outward IK tail
currents. The current-voltage (I-V) relationships measured at the
beginning and the end of each step are shown in Fig. 2B (closed and
open circles, respectively). At potentials negative to
40 mV, both the I-V curves inwardly rectified due to the IK1
currents. At potentials positive to
40 mV, the instantaneous I-V
curve exhibited the U shape with a peak at 0 mV reflecting the inward
L-type ICa current. On the other
hand, the steady-state I-V curve gradually increased in the positive
direction as the membrane potential was depolarized. This was due to
the IK currents.
|
80 mV
elicited slowly developing large inward currents (Fig. 2A, b). These
are Ach-induced KACh currents (Yamada et al.,
1998
40 mV, large outward tail currents
appeared due to the slow deactivation of the currents. The steady-state I-V curve (Fig. 2B, open squares) exhibited inward rectification and
crossed the control steady-state I-V curve at ~
80 mV. At potentials
more negative than
40 mV, the absolute amplitudes of the steady-state
currents (open squares) were always larger than those of the
instantaneous currents (closed squares) because of the relaxation of
KACh currents. At potentials positive to
40
mV, ACh caused a roughly parallel shift of the control instantaneous and steady-state I-V curves in the positive direction, suggesting that
ACh did not significantly affect the ICa or
IK currents.
Tertiapin (100 nM) applied in the presence of ACh almost completely
abolished the KACh currents (Fig. 2, A, c, and B,
triangles). When ACh was washed out in the presence of tertiapin,
inward currents at potentials negative to
80 mV slightly decreased
(Fig. 2A, d), indicating that tertiapin (100 nM) did not completely
inhibit KACh channels. The I-V relationships in
the presence of tertiapin alone (Fig. 2B, inverted triangles) were
almost identical to those under the control condition (circles), except
that the current amplitude at
100 mV was slightly smaller with
tertiapin. Therefore, tertiapin (100 nM) almost completely inhibited
KACh currents and only slightly inhibited
IK1 currents without significantly affecting other channel currents.
Effect of Tertiapin on KATP Channels in Rabbit
Ventricular Myocytes.
Figure 3
depicts the effect of tertiapin on another Kir channel in cardiac
myocyte, the KATP channel. These traces were
recorded from a ventricular myocyte. In the ventricular myocyte, there was a much larger IK1 current than in atrial
myocytes (cf. Fig. 2A, a). Under the control condition, the
steady-state I-V curve (Fig. 3B, open circles) was in an N shape due to
the strong inward rectification of IK1
channels (Kurachi, 1985
). Pinacidil (100 µM), an activator of
KATP channels, induced large time-independent outward currents at potentials more positive than
70 mV (Fig. 3A, b)
(Terzic et al., 1995
). However, inward currents at potentials negative
to
80 mV did not increase as prominently; this is because the inward
rectification of KATP channels is so weak that
the current exhibits even a slightly outward rectification in the presence of 5.4 mM extracellular K+ as expected
from the constant field theory (Findlay, 1987
). Therefore, the inward
rectification of the steady-state I-V relationship became weaker after
the application of pinacidil than the control (Fig. 3B, open squares).
The ICa currents (roughly estimated as a
difference between the instantaneous and the steady-state currents at

30 mV) became smaller after the application of pinacidil. This was
probably due to the rundown of ICa channels
(McDonald et al., 1994
). Tertiapin (1 µM) did not significantly
inhibit the pinacidil-induced currents (Fig. 3A, c, and B, triangles), whereas glibenclamide (1 µM), a specific inhibitor of
KATP channels, strongly suppressed the
KATP currents (Fig. 3A, d) (Terzic et al., 1995
).
Under this condition, the steady-state currents (Fig. 3B, open inverted
triangles) at potentials negative to
80 mV were slightly smaller than
those under the control condition. This is probably because of the weak
inhibitory effect of tertiapin on IK1 channel
currents. In summary, tertiapin (1 µM) did not significantly inhibit
KATP channels. This observation was confirmed in
two additional experiments with different ventricular myocytes (not
shown).
|
Concentration-Dependent Inhibition of KACh and
IK1 Channels by Tertiapin.
We next examined the
concentration-dependent effect of tertiapin on
KACh and IK1 channels (Fig.
4). The upper row in Fig. 4A depicts a
continuous recording of the whole-cell current of an atrial myocyte.
Throughout the experiment, three consecutive voltage steps to
100,
40, and +10 mV were applied from the holding potential of
40 mV
every 3 s (left bottom corner of Fig. 4A). The duration of each
the step was 300 ms. The thick lines above the current trace indicate
the perfusion protocol, according to which the experiment was divided
into four parts (indicated by thin lines 1-4).
|
100 mV
elicited an inward IK1 current; the second step to
40 mV, a large transient inward Na+ current;
and the final step to +10 mV, a slow inward ICa
current followed by an outward IK current. Open
and closed circles in the trace (and in all other traces in this
figure) indicate the quasi-steady-state amplitude of the currents at
40 and
100 mV, respectively
[I(t)
40 and
I(t)
100, where t is the time after the application of ACh in s]. The average values of I(t)
40 and
I(t)
100 in part 1 (mI
40(1) and mI
100(1))
were 3.97 and
103.47 pA, respectively.
The application of ACh (1 µM) suddenly activated
KACh channels and increased the currents in the
positive direction at
40 and +10 mV and in the negative direction at
100 mV (part 2 and trace b). The currents gradually decreased due to
the short-term desensitization of KACh channels
(part 2 and trace c). The decay of
I(t)
40 and
I(t)
100 in part 2 was fit by the
following biexponential functions:
|
(2) |
|
(3) |
40(t) and
f
100(t) are in pA. These
curves were extended to the end of part 3 and represented as lines f
and g, respectively. The curves predict how KACh
currents would have decreased spontaneously if tertiapin had not been
applied. Tertiapin (10 nM) applied in the middle of the desensitization reduced the KACh currents much faster than
expected from the curves (part 3 and trace d).
When ACh was washed out in the presence of tertiapin (part 4), the
remaining currents quickly decreased due to the prompt deactivation of
KACh channels (see also trace e). The averaged values of I
40(t) and
I
100(t) in part 4 [mI
40(4) and
mI
100(4)] were
6.25 and
96.56 pA, respectively.
To quantitatively estimate the effect of tertiapin on
KACh currents, ACh-induced currents in parts 2 and 3 were normalized to those predicted by eqs. 2 and 3. This was done
by the following calculations:
In part 2,
|
(4) |
|
(5) |
|
(6) |
|
(7) |
40 and
nI(t)
100 are normalized ACh-induced
currents at
40 and
100 mV, respectively. We plotted the calculated
values against time t in Fig. 4B. Both
nI(t)
40 (open circles) and
nI(t)
100 (closed circles) gradually decreased to steady-state values within ~40 s after the application of tertiapin. The amplitudes of the normalized currents between 95 and
135 s were 0.60 and 0.64 at
40 and
100 mV, respectively (indicated by lines designated
40 and
100 mV). Thus, tertiapin (10 nM) decreased ACh-induced KACh currents in a
similar time course to ~60% independent of the membrane potential.
We also examined whether tertiapin modulated the kinetics of the slow
relaxation of KACh channels (Fig. 4C). The trace
c
a is the subtraction of trace a from trace c and corresponds
to the ACh-induced current at time c. From
f
100(t),
I(t)
100 would have decreased to 77%
at time d if tertiapin had not been applied. Thus, the ACh-induced
current at time d in the absence of tertiapin is represented as trace
0.77c
a. The nI(t)
100 indicates that this current further decreased to 64% in the presence of tertiapin (Fig. 4B), which is shown as trace 0.64(0.77c
a) (dotted line). This current trace reasonably overlapped the real ACh-induced current measured at time d (trace d
e, solid line) at
100,
40, and +10 mV. Thus, tertiapin did not change the
relaxation kinetics of KACh channels.
By repeating these experiments with different concentrations of
tertiapin, we assessed the concentration-dependent effect of tertiapin
on KACh channels. Figure
5 summarizes the results. Open and closed
circles indicate the averaged values of
nI(t)
40 and
nI(t)
100, respectively. Bars are
S.E. values at each point. No significant difference was found between
nI(t)
40 and
nI(t)
100 at any concentration of
tertiapin. Dotted and solid lines are, respectively, the fit of the
data at
40 and
100 mV by the following Hill equation:
|
(8) |
40 or
nI(t)
100, [tertiapin] is the
concentration of tertiapin in M, Kd is
the dissociation constant in M, and n is the Hill
coefficient. Kd and n were
estimated as 7.4 nM and 0.81 at
40 mV and as 8.4 nM and 0.82 at
100
mV, respectively. These results indicate that tertiapin inhibited KACh channels in a voltage-independent manner
through approximately 1:1 stoichiometry. Squares in the graph represent
the data for IK1 channels. These values were
obtained as the ratio
mI
100(4)/mI
100(1). Tertiapin was at least 100 times less potent in inhibiting
IK1 than KACh channels.
|
Inhibitory Effect of Tertiapin on KACh Channels Is Not
Mediated by Muscarinic Receptors.
One possible explanation for the
selective inhibitory effect of tertiapin on KACh
channels might be that tertiapin impaired activation of
KACh channels through an antagonistic effect on muscarinic receptors. This possibility is, however, denied in Fig.
6. Here, the whole-cell current was
measured in an atrial myocyte with a pipette containing 10 µM
GTP
S, a hydrolysis-resistant analog of GTP. GTP
S can fully
activate KACh channels in the absence of any
receptor agonists (Ito et al., 1991
; Kurachi et al., 1996
; Yamada et
al., 1998
). From the holding potential of
40 mV, the voltage pulse
shown in Fig. 4A was applied every 5 s. This current trace started
~2 min after formation of the whole-cell configuration. In this
particular experiment, GTP
S already activated
KACh channels to a stable level from the very
beginning of the recording (Fig. 6, A and B, trace a). Tertiapin (100 nM) suppressed the GTP
S-induced KACh currents to leave the inactivating
IK1 current at
100 mV (Fig. 6B, trace b).
Subtraction of the current before the application of tertiapin from
that after the application of tertiapin yielded a tertiapin-sensitive
current (Fig. 6B, trace a
b). This current exhibited the
typical slow relaxation of KACh channels. Similar results were obtained in two other experiments (not shown). Thus, tertiapin inhibited KACh channels in a
receptor-independent manner.
|
Effect of Tertiapin on KACh Channels at Single-Channel
Level.
Figure 7A shows the
single-channel recordings of KACh channels in the
cell-attached configuration with the pipette filled with
K+ external solution containing 145 mM KCl and 1 µM ACh with or without 30 nM tertiapin. The cell membrane potential
was zeroed by bath perfusion of the internal solution, whereas the
patch membrane potential was changed by altering the pipette potential. In the absence of tertiapin (left), numerous brief inward
KACh currents appeared at potentials negative to
EK (~0 mV under this condition) (Sakmann et
al., 1983
). At potentials positive to EK, only
small outward currents were occasionally seen due to the inward
rectification of the channel (Yamada and Kurachi, 1995
). In the
presence of tertiapin (right), the amplitude of single-channel KACh currents was not significantly different
from the control at each membrane potential. Figure 7B depicts the
single-channel I-V relationship of KACh channels
in the absence (open circles) and presence (closed circles) of 30 nM
tertiapin (n = 3 for each point). The linear fit of the
averaged data gave the estimate of the single
KACh channel conductance of 44.2 pS in the
absence of tertiapin (dotted line) and 46.9 pS in the presence of
tertiapin (solid line). Thus, tertiapin did not reduce the
single-channel conductance of KACh channels.
|
60 mV. ACh (1 µM) strongly induced inward KACh currents, which was substantially inhibited by 100 nM tertiapin. The two left
graphs under the trace are the amplitude histograms constructed from
parts a and b in the record. In the presence of ACh alone (part a),
multiple channels opened simultaneously (top graph). The first obvious
four peaks could be fit by gaussian curves (lines), which indicated the
single-channel amplitude of
2.05 pA. By dividing the mean current
amplitude in part a by this value, the NPo was calculated to be 6.41 (N is the number of functional channels in the
patch, and Po is the open probability of each
channel). In the presence of ACh and tertiapin (part b), the amplitude
histogram exhibited five peaks (bottom graph). Fitting of this
histogram by gaussian curves (lines) gave the single-channel amplitude
of
1.98 pA. From this value and the mean current amplitude in part b,
NPo was calculated as 1.62 in the presence of ACh
and tertiapin. Therefore, tertiapin inhibited
KACh channels by reducing
NPo without changing the single-channel
conductance.
|
|
S or tertiapin. The membrane potential was held at
60 mV. KACh channels were irreversibly
activated with 10 µM GTP
S and then exposed to intracellular tertiapin (100 nM). Tertiapin did not significantly reduce the single-channel amplitude or NPo of
KACh channels. Thus, the receptor site for
tertiapin resides in the extracellular surface of the channel molecule.
| |
Discussion |
|---|
|
|
|---|
We have shown that tertiapin potently suppressed ACh-induced
KACh channel currents in rabbit cardiac myocytes
(Kd ~ 8 nM) (Figs. 2, 4, and 5).
Tertiapin also inhibited IK1 channels, but by
only less than 10% at 1 µM (Fig. 5). Thus, tertiapin was at least
100 time more potent in inhibiting KACh than
IK1 channels. The other ion channels, including
KATP channels, were virtually insensitive to the
toxin (Figs. 2 and 3). Tertiapin inhibited KACh
channels in a voltage- and receptor-independent manner without affecting the slow relaxation (Figs. 4-6). At the single-channel level, tertiapin reduced NPo without
significantly affecting the single-channel conductance or the fast
open-closed kinetics (Figs. 7 and 8; Table 1). Therefore, tertiapin is
likely to cause a slow block on KACh channels,
consistent with the high affinity of the toxin for the channels (Hille,
1992
).
Jin and Lu (1998)
found that tertiapin selectively blocks certain types
of recombinant Kir channels expressed in Xenopus oocytes. Kir channels are formed by four subunits, each of which has two transmembrane segments (Ho et al., 1993
; Kubo et al., 1993a
; Yang et
al., 1995
). At least 13 distinct genes for Kir subunits have been
identified and classified into six groups according to their primary
structure (Kir1.x-Kir6.x; Doupnik et al., 1995
). A homotetramer of
Kir1.1 (ROMK1) subunits is a weak inward rectifier involved in the
electrolyte metabolism in renal tubules but not expressed in the heart
(Ho et al., 1993
). Kir2.x (IRKx) subunits form as a homotetramer the
strong inward rectifier in heart, muscle, and brain (Kubo et al., 1993
;
Morishige et al., 1994
; Takahashi et al., 1994
). Kir3.x (GIRKx)
subunits make up G protein-gated Kir channels in heart, brain, and
endocrine organs by forming either a homotetrameric or heterotetrameric
complex (Kubo et al., 1993b
; Krapivinsky et al., 1995
; Yamada et al.,
1998
). Tertiapin blocks the homomeric Kir1.1 channel and the
heteromeric Kir3.1/Kir3.4 channel with a
Kd value of ~2 and ~8 nM,
respectively, but blocks Kir2.1 channels by only less than 10% at 1 µM (Jin and Lu, 1998
). These results are very consistent with what we
found in the present study. The Kir3.1/Kir3.4 channel has been
considered the cardiac KACh channel based on
biochemical and functional studies (Krapivinsky et al., 1995
). The
equivalent potency of tertiapin (Kd ~ 8 nM) for the native KACh and the recombinant
Kir3.1/Kir3.4 channels strongly supports this hypothesis.
IK1 channels were as insensitive to tertiapin as
the Kir2.1 channel. However, the native IK1
channel is more similar to the Kir2.2 than the Kir2.1 channel in
single-channel conductance and kinetics (Takahashi et al., 1994
;
Isomoto et al., 1997
; Matsumoto et al., 1999
). Therefore, the
sensitivity of the Kir2.2 channel to tertiapin also must be examined.
The cardiac KATP channel is a hetero-octamer
composed of four Kir6.2 subunits and four sulfonylurea receptors,
ATP-binding cassette protein (Inagaki et al., 1996
; Okuyama et al.,
1998
). The present study indicates that Kir6.2 channels are also
insensitive to tertiapin (Fig. 3).
A Kir subunit has a domain referred to as a P or an H5 region between
the two transmembrane segments (Kubo et al., 1993a
; Isomoto et al.,
1997
). This region forms a K+ channel pore
(Hartmann et al., 1991
; Yellen et al., 1991
). A site-directed
mutagenesis on the P region of Kir1.1 subunit identified amino acids
involved in the tertiapin binding (Jin and Lu, 1998
). These residues
are mainly located both amino and carboxyl terminal to the
K+ channel signature sequence that forms the
K+ selectivity filter (Heginbotham et al., 1994
).
A recent crystallographic analysis of the three-dimensional structure
of a voltage-dependent K+ channel indicates that
these two regions form the turret and the vestibule base, respectively,
within the outermost part of the channel pore (Doyle et al., 1998
).
Although no structural information is available on the tertiapin
binding site or sites in the Kir3.1/Kir3.4 channel, what is predicted
from the structural analyses agrees with the observed voltage- and
receptor-independent effect of extracellular tertiapin (Figs. 5 and 6)
and the ineffectiveness of intracellular tertiapin on
KACh channels (Fig. 8B). One amino acid (F137) in
the P region of Kir3.1 may be responsible for the slow relaxation of
KACh channels (Kofuji et al., 1996
). The
corresponding residue in Kir1.1 subunit (S135) does not significantly
contribute to the tertiapin interaction (Jin and Lu, 1998
), which is
consistent with the lack of the effect of tertiapin on the slow
relaxation kinetics (Fig. 4C). Although we could not analyze in detail
the single-channel kinetics of KACh channels,
tertiapin seems to cause a slow block on the channels (Hille, 1992
).
The state dependence of the tertiapin block is unknown, but
KACh channels do not have to open to interact
with tertiapin because KACh channels became refractory to ACh (1 µM) when pretreated with 100 nM tertiapin (not
shown). Detailed structural and functional analyses of the interaction
of tertiapin and KACh (or Kir3.1/Kir3.4) channels will delineate the pore structure and the mechanism of the gating of
the heterotetrameric ion channel.
To summarize, tertiapin potently and specifically blocks KACh channels in cardiac myocytes. Tertiapin can therefore be a powerful pharmacological tool to identify the functional role of KACh channels in the cardiac physiology and pathophysiology.
| |
Acknowledgments |
|---|
We are grateful to Dr. Takushi X. Watanabe (Peptide Institute Inc., Osaka, Japan) for technical advice on the handling of tertiapin.
| |
Footnotes |
|---|
Accepted for publication December 21, 1999.
Received for publication October 27, 1999.
1 This work was supported by a Research Grant for Cardiovascular Diseases (11C-1) from the Ministry of Health and Welfare of Japan and a grant from Japan Cardiovascular Research Foundation to M. Yamada.
Send reprint requests to: Mitsuhiko Yamada, MD, PhD, Department of Cardiac Physiology, National Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565 Japan. E-mail: yamadacp{at}jsc.ri.ncvc.go.jp
| |
Abbreviations |
|---|
Kir, inwardly rectifying K+;
KACh, muscarinic K+;
NPo, product
of the number of functional channels and the open probability of each
channel;
EK, potassium equilibration potential;
KATP, ATP-sensitive K+;
GTP
S, guanosine
5'-O-(3-thiotriphosphate);
ICa, voltage-dependent Ca2+ current: IK,
voltage-dependent K+ current;
I-V, current-voltage;
ACh, acetylcholine.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Z. Zuberi, L. Birnbaumer, and A. Tinker The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1822 - R1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Sattler, S. K. Williams, C. Neusch, M. Otto, J. R. Pehlke, M. Bahr, and R. Diem Flupirtine as Neuroprotective Add-On Therapy in Autoimmune Optic Neuritis Am. J. Pathol., November 1, 2008; 173(5): 1496 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Troncoso Brindeiro, R. W. Fallet, P. H. Lane, and P. K. Carmines Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney Am J Physiol Renal Physiol, July 1, 2008; 295(1): F171 - F178. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Landeen, D. A. Dederko, C. S. Kondo, B. S. Hu, N. Aroonsakool, J. H. Haga, and W. R. Giles Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H736 - H749. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Voigt, A. Maguy, Y.-H. Yeh, X. Qi, U. Ravens, D. Dobrev, and S. Nattel Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes Cardiovasc Res, January 1, 2008; 77(1): 35 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mintert, L. I. Bosche, A. Rinne, M. Timpert, M.-C. Kienitz, L. Pott, and K. Bender Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4 J. Physiol., November 15, 2007; 585(1): 3 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mizuno, A. Kamiya, T. Kawada, T. Miyamoto, S. Shimizu, and M. Sugimachi Muscarinic potassium channels augment dynamic and static heart rate responses to vagal stimulation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1564 - H1570. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rubinstein, S. Peleg, S. Berlin, D. Brass, and N. Dascal G{alpha}i3 primes the G protein-activated K+ channels for activation by coexpressed Gbeta{gamma} in intact Xenopus oocytes J. Physiol., May 15, 2007; 581(1): 17 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Cha, J. R. Ehrlich, D. Chartier, X.-Y. Qi, L. Xiao, and S. Nattel Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias Circulation, April 11, 2006; 113(14): 1730 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dobrev, A. Friedrich, N. Voigt, N. Jost, E. Wettwer, T. Christ, M. Knaut, and U. Ravens The G Protein-Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation Circulation, December 13, 2005; 112(24): 3697 - 3706. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kanjhan, E. J. Coulson, D. J. Adams, and M. C. Bellingham Tertiapin-Q Blocks Recombinant and Native Large Conductance K+ Channels in a Use-Dependent Manner J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1353 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bender, M.-C. Wellner-Kienitz, L. I Bosche, A. Rinne, C. Beckmann, and L. Pott Acute desensitization of GIRK current in rat atrial myocytes is related to K+ current flow J. Physiol., December 1, 2004; 561(2): 471 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ehrlich, T.-J. Cha, L. Zhang, D. Chartier, L. Villeneuve, T. E. Hebert, and S. Nattel Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium J. Physiol., June 1, 2004; 557(2): 583 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Michel, J. M. Robillard, and L.-E. Trudeau Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors J. Physiol., April 15, 2004; 556(2): 429 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Chauhan, H. Nilsson, A. Ahluwalia, and A. J. Hobbs Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor PNAS, February 4, 2003; 100(3): 1426 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Kuzhikandathil and G. S. Oxford Classic D1 Dopamine Receptor Antagonist R-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) Directly Inhibits G Protein-Coupled Inwardly Rectifying Potassium Channels Mol. Pharmacol., July 1, 2002; 62(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takigawa and C. Alzheimer Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells J. Physiol., February 15, 2002; 539(1): 67 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada The Role of Muscarinic K+ Channels in the Negative Chronotropic Effect of a Muscarinic Agonist J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 681 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seeger and C. Alzheimer Muscarinic activation of inwardly rectifying K+ conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells J. Physiol., September 1, 2001; 535(2): 383 - 396. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||